Admission and introduction of shares of H series to public trading
Current Report no 10/2022
Legal basis: Article 56(1)(2) of the Act on Public Offering – current and periodical information
The Management Board of Medicalgorithmics S.A. (“Company”) informs that today received information about the adoption on 23 February 2022 by the Management Board of the Warsaw Stock Exchange of Resolution No. 174/2022 concerning the admission and the introduction to trading on Warsaw Stock Exchange (WSE) of series H bearer ordinary shares of the company MEDICALGORITHMICS S.A, in which the WSE Management Board states that pursuant to § 19.1 and § 19.2 of the WSE Rules 648 556 series H bearer ordinary shares of the company MEDICALGORITHMICS S.A., a par value PLN 0.10 each, are admitted to exchange trading on the main market.
Furthermore, pursuant to § 36, § 37 and § 38 (1) and (3), in connection with § 3a (1), (2) and (3) of the WSE Rules, the WSE Management Board resolves to introduce as of 25 February 2022 to exchange trading with the WSE the above mentioned shares of the company MEDICALGORITHMICS S.A., conditional on the registration of these shares and their coding as “PLMDCLG00015” by Krajowy Depozyt Papierów Wartościowych S.A. (KDPW) on 25 February 2022.
Additionally, the Management Board of the Company informs that today received a communication from KDPW informing that on February 25, 2022, 648,556 series H ordinary bearer shares will be registered with the KDPW.